Mirati (MRTX) Down 17.6% Since Last Earnings Report: Can It Rebound?

Logo NasdaqNasdaq
2023-06-08 15:30:59  • 5 mins

It has been about a month since the last earnings report for Mirati (MRTX). Shares have lost about 17.6% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Mirati due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.

Q1 Earnings & Sales Beat Estimates

Mirati reported a loss of $3.18 per share for first-quarter 2023, narrower than the Zacks Consensus Estimate of a loss of $3.47 as well as the year-ago quarters loss of $3.40 per share.

Mirati reported $7.2 million in revenues for the first quarter, beating the Zacks Consensus Estimate of $5 million. Mirati had recorded revenues of $1 million in the year-ago quarter.

Quarter in Detail

First-quarter revenues included $6.3 million as product revenues from Krazati/adagrasib, Miratis newly approved cancer drug.The first quarter of 2023 was the first full quarter of Krazati revenues. In fourth-quarter 2022, Krazati generated initial sales of $0.7 million which was mostly associated with inventory in the channel.

Continue read on nasdaq.com

Fintel reports that on September 28, 2023, JMP Securities reiterated coverage of Mirati Therapeutics ( NASDAQ:MRTX ) with a Market Outperform recommendation....
Logo NasdaqNasdaq
2023-09-28 20:00:52  • 1 min
September has historically been the worst month (by a wide margin) for the S&P 500. That strange phenomenon, referred to as the September Effect, hit the...
Logo NasdaqNasdaq
2023-09-30 11:05:00  • 2 mins
While most stocks like to stay as far away from market volatility as possible, MarketAxess (NASDAQ: MKTX) and its electronic bond-trading platform play a...
Logo NasdaqNasdaq
2023-09-30 12:30:00  • 1 min
RTX Corp (NYSE: RTX) hasn't delivered great results in recent years, with new problems to deal with after a big merger. In this video, Motley Fool...
Logo NasdaqNasdaq
2023-09-30 10:02:00  • 1 min
Fintel reports that on September 29, 2023, UBS initiated coverage of Treace Medical Concepts ( NASDAQ:TMCI ) with a Buy recommendation. Analyst Price...
Logo NasdaqNasdaq
2023-09-30 14:09:30  • 1 min
Electric vehicle company Tesla (NASDAQ: TSLA) is currently sitting pretty. The company is slashing prices to take market share at a time when labor strikes...
Logo NasdaqNasdaq
2023-09-30 11:30:00  • 1 min
Fool.com contributor Parkev Tatevosian discusses an investor update where CrowdStrike (NASDAQ: CRWD) told shareholders the future is brighter. *Stock prices...
Logo NasdaqNasdaq
2023-09-30 14:15:00  • 1 min
A month has gone by since the last earnings report for Pure Storage (PSTG). Shares have lost about 4% in that time frame, outperforming the S&P 500. Will...
Logo NasdaqNasdaq
2023-09-29 15:30:08  • 1 min
The Singapore stock market on Thursday ended the two-day slide in which it had fallen almost 20 points or 0.6 percent. The Straits Times Index now sits just...
Logo RTTNewsRTTNews
2023-09-28 23:30:11  • 2 mins
Fintel reports that on September 29, 2023, Alembic Global initiated coverage of RTX ( NYSE:RTX ) with a Neutral recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-30 01:49:48  • 1 min
Rounding out September and heading into the fourth quarter the broader technology sector has lost some steam with the Nasdaq down -6% for the month but still...
Logo NasdaqNasdaq
2023-09-30 01:05:00  • 1 min
Year to date, tech stocks are still on track for a banner year, but some of the air in the rally has come out over the last month or two. Enthusiasm about...
Logo NasdaqNasdaq
2023-09-30 11:53:00  • 1 min
FXEmpire.com - Key Insights: On Friday, XRP witnessed a bullish gain, wrapping the day at $0.5216, following Thursdays uptrend. Amicus Curiae attorney, John...
Logo NasdaqNasdaq
2023-09-30 02:49:40  • 1 min
The markets have given investors a wild ride over the last three years, and that has resulted in several promising companies selling at deeply discounted...
Logo NasdaqNasdaq
2023-09-30 11:20:00  • 2 mins
Fintel reports that on September 29, 2023, Goldman Sachs maintained coverage of Safehold ( NYSE:SAFE ) with a Buy recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-30 02:14:43  • 1 min
When given time, Wall Street is a bona fide money machine. But over shorter timelines, directional movements in the broader market are unpredictable, as the...
Logo NasdaqNasdaq
2023-09-30 09:06:00  • 1 min
Tractor Supply (NASDAQ: TSCO) stock is down 18% as of this writing from its recent high, and faces some potential headwinds. But with great growth prospects,...
Logo NasdaqNasdaq
2023-09-30 09:03:00  • 1 min
Sea Limited (NYSE: SE) has been a problem child for investors over the last two years as evidenced by the 88% decline in the stock price from its peak of...
Logo NasdaqNasdaq
2023-09-30 12:10:00  • 1 min
Fool.com contributor Parkev Tatevosian evaluates The Trade Desk (NASDAQ: TTD) and its long-term prospects to determine if investors should buy. *Stock prices...
Logo NasdaqNasdaq
2023-09-30 19:00:00  • 1 min
Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical stage company that mixes healthcare with technology and artificial intelligence (AI). Its drug...
Logo NasdaqNasdaq
2023-09-30 13:15:00  • 2 mins